JENNIFER DEMKO: Open Payments
NPI 1851157051 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,751 in 82 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $511 · 2025 $1,751
Food & beverage: $1,751
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $588 |
| Otsuka America Pharmaceutical, Inc. | 7 | $218 |
| Vanda Pharmaceuticals Inc. | 11 | $172 |
| Alkermes, Inc. | 5 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $143 |
| Janssen Pharmaceuticals, Inc | 5 | $117 |
| Neurocrine BioSciences, Inc. | 4 | $80 |
| Axsome Therapeutics, Inc. | 2 | $63 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
Products named: VRAYLAR, CAPLYTA, HETLIOZ, ABILIFY MAINTENA, LYBALVI, REXULTI, SPRAVATO, INGREZZA.
Industry payments across FL — which companies pay providers there.
